Related Experiment Video
Updated: Jan 27, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Infant Outcomes, Risk Factors, and Diagnostic Yield After a Brief Resolved Unexplained Event: A Systematic Review and
Nassr Nama1, Stephanie Liebert1, Mario Abaji2
1Department of Pediatrics, Division of Hospital Medicine, University of Washington School of Medicine, Seattle Children's Hospital, Seattle.
Insights
Brief Resolved Unexplained Events (BRUE) in infants rarely lead to serious diagnoses or death. Most routine tests offer little value, suggesting a shift to risk-informed clinical approaches for better infant care.
Area of Science:
- Pediatric Emergency Medicine
- Neonatology
- Clinical Epidemiology
Background:
- Clinical uncertainty persists regarding Brief Resolved Unexplained Events (BRUE) due to limited research.
- Variations in clinical practice arise from conflicting data on adverse outcomes, risk factors, and diagnostic utility.
Purpose of the Study:
- To determine the frequency of serious underlying diagnoses and 3-month mortality in infants following a BRUE.
- To identify prognostic risk factors for adverse outcomes.
- To quantify the diagnostic yield of common investigations for BRUE.
Main Methods:
- Systematic review and meta-analysis of cohort studies, case-control studies, and clinical trials.
- Searched PubMed, Embase, Cochrane, and gray literature (January 2016-July 2025).
- Pooled prevalence, mortality, risk factors, and diagnostic yield using random-effects meta-analyses; assessed evidence certainty with GRADE.
Main Results:
- 24 studies including 6603 infants were analyzed.
- Serious underlying diagnosis prevalence was 6.0% (high certainty); 3-month mortality was rare (1 in 1851 infants, moderate certainty).
- Multiple events history and prematurity increased risk for serious diagnosis; routine tests (metabolic panels, ECGs, chest X-rays) showed very low diagnostic yield.
Conclusions:
- Infant mortality after BRUE is exceedingly rare, with serious underlying diagnoses in a small percentage.
- Most routine diagnostic tests provide minimal value and can yield false positives.
- Clinical practice should transition to targeted, risk-informed evaluations for BRUE, guiding guideline revisions.
Importance:
Since the introduction of the brief resolved unexplained event (BRUE) terminology, underpowered and conflicting research has led to persistent clinical uncertainty regarding the frequency of adverse outcomes, prognostic risk factors, and the diagnostic testing utility, contributing to wide practice variations.
Objective:
To (1) establish the frequency of serious underlying diagnoses and 3-month mortality after a BRUE in infants; (2) identify prognostic risk factors; and (3) quantify the diagnostic yield of common investigations.
Data Sources:
PubMed, Embase, Cochrane, and gray literature sources from January 2016 through July 2025.
Study Selection:
Cohort studies, case-control studies, and clinical trials of infants meeting 2016 American Academy of Pediatrics diagnostic criteria for BRUE.
Data Extraction And Synthesis:
Data were extracted by 1 reviewer and verified by a second. Random-effects meta-analyses were used to pool data. Grading of Recommendations Assessment, Development, and Evaluation was used to assess certainty in evidence.
Main Outcomes And Measures:
The primary outcomes were pooled prevalence of serious underlying diagnosis and 3-month cumulative mortality. Secondary outcomes included prognostic risk factors and diagnostic yield of specific tests.
Results:
From 664 citations, 24 studies (6603 infants) were included. The pooled prevalence of a serious underlying diagnosis was 6.0% (95% CI, 4.6%-7.9%; high certainty), and cumulative 3-month mortality was 1 death per 1851 infants (95% CI, 1 death per 597-5739 infants; moderate certainty). A history of multiple events (risk difference [RD], 3.7%; 95% CI, 1.7%-6.2%; high certainty) and prematurity (RD, 2.6%; 95% CI, 0.6%-5.2%; high certainty) were associated with increased risk of serious underlying diagnosis, while being aged 60 days or younger was not (RD, -0.5%; 95% CI, -2.7% to 3.0%; high certainty). Routine investigations were exceedingly low yield: metabolic panels had 0% yield (95% CI, 0%-0.5%; number needed to test [NNT] = 852; moderate certainty), electrocardiograms, 0.2% yield (95% CI, 0.0%-0.9%; NNT = 623; high certainty); and chest radiographs, 0.4% yield (95% CI, 0.2%-1.0%; NNT = 256; high certainty).
Conclusions And Relevance:
This systematic review and meta-analysis found that infant mortality after a BRUE was exceedingly rare, and a serious underlying diagnosis was present in a small but important group of infants; most routine diagnostic tests added little value and not infrequently had false-positive results. Clinical focus should therefore shift from blanket investigations to a targeted, risk-informed approach grounded in a few reliable higher-risk features. These findings provide a robust evidence basis for guideline revision.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
ATP Yield
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
Reaction Yield
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors

